Switch to
Predicate | Object |
---|---|
rdf:type | |
calbc:hasCorrelation | |
skos:definition |
PDQ: A recombinant, humanized anti-CD33 monoclonal antibody attached to the cytotoxic antitumor antibiotic calicheamicin. In this conjugate, the antibody binds to and is internalized by tumor cells expressing CD33 antigen (a sialic acid-dependent glycoprotein commonly found on the surface of leukemic blasts), thereby delivering the attached calicheamicin to CD33-expressing tumor cells. Calicheamicin binds to the minor groove of DNA, causing double strand DNA breaks and resulting in inhibition of DNA synthesis. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=42868&idtype=1" active clinical trials or "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=42868&idtype=1&closed=1" closed clinical trials using this agent. ("http://nciterms.nci.nih.gov:80/NCIBrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C1806" NCI Thesaurus),NCI: A recombinant, humanized anti-CD33 monoclonal antibody attached to the cytotoxic antitumor antibiotic calicheamicin. In this conjugate, the antibody binds to
|
skos:inScheme | |
skos-xl:prefLabel | |
skos-xl:altLabel |
umls-label:A20633567,
umls-label:A16472947,
umls-label:A16759864,
umls-label:A17913129,
umls-label:A17960946,
umls-label:A8438648,
umls-label:A17388784,
umls-label:A10774452,
umls-label:A18569266,
umls-label:A1889604,
umls-label:A4358514,
umls-label:A8397518,
umls-label:A7668896,
umls-label:A7667556,
umls-label:A11920063,
umls-label:A7638904,
umls-label:A11914440
|